Laurence H. Brinckerhoff

Terminal modifications inhibit proteolytic degradation of an immunogenic mart-127-35 peptide: Implications for peptide vaccines

Laurence H. Brinckerhoff, Lee W. Thompson, Galina V. Yamshchikov et al. · International Journal of Cancer · 1999 · 168 citations

Terminal Modifications, Immunology, Peptide Vaccines +22

Activated α2-Macroglobulin Reverses the Immunosuppressive Activity in Human Breast Cancer Cell-Conditioned Medium by Selectively Neutralizing Transforming Growth Factor-β in the Presence of Interleukin-2

Nancy L. Harthun, Alissa M. Weaver, Laurence H. Brinckerhoff et al. · Journal of Immunotherapy · 1998 · 17 citations

α2-Macroglobulin Reverses, Breast Oncology, Immunology +20

Pseudomonas Exotoxin-Mediated Delivery of Exogenous Antigens to MHC Class I and Class II Processing Pathways

John D. Lippolis, Kimberly Denis-Mize, Laurence H. Brinckerhoff et al. · Cellular Immunology · 2000 · 16 citations

Microbial Toxin, Exogenous Antigens, Mhc Class +9

Competition Among Peptides in Melanoma Vaccines for Binding to MHC Molecules

Lee W. Thompson, Courtney F. Garbee, S. Hibbitts et al. · Journal of Immunotherapy · 2004 · 14 citations

Preventing the Spontaneous Modification of an HLA-A2-Restricted Peptide at an N-Terminal Glutamine or an Internal Cysteine Residue Enhances Peptide Antigenicity

Lee W. Thompson, Kevin T. Hogan, Jennifer Caldwell et al. · Journal of Immunotherapy · 2004 · 10 citations